{
  "docId": "019de071-d756-7568-8588-410684bab010",
  "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4",
  "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 23,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 48,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/7",
  "deckHref": "/decks/019de071-d756-7568-8588-410684bab010",
  "deckJsonHref": "/decks/019de071-d756-7568-8588-410684bab010.json",
  "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.776,
        "x": 0.112,
        "y": 0.215
      },
      "kind": "table",
      "text": "Demographic Characteristic, Pegzilarginase n=21, Placebo n=11, Overall N=32, Age at Enrollment, y, Mean (SD), 9.6 (6.16), 12.9 (6.77), 10.7 (6.47), Range, 2-28, 5-29, 2-29, Age Category, n (%), 2y to less than 6y, 5 (23.8), 1 (9.1), 6 (18.8), 6y to less than 12y, 8 (38.1), 4 (36.4), 12 (37.5), 12y to less than 18y, 7 (33.3), 4 (36.3), 11 (34.4), 18y or older, 1 (4.8), 2 (18.2), 3 (9.4), Sex, n (%), Male, 12 (57.1), 7 (63.6), 19 (59.4), Female, 9 (42.9), 4 (36.4), 13 (40.6), Region, n (%), U.S., 8 (38.1), 6 (54.5), 14 (43.8), Ex-U.S., 13 (61.9), 5 (45.5), 18 (56.3)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "694180bc-dbf3-4deb-b5d3-d9bdac4cca86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.424,
        "x": 0.068,
        "y": 0.045
      },
      "kind": "title",
      "text": "PEACE Baseline Demographics",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d193a7d6-f0ca-473f-909f-97edb9f51d62",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 5,
      "beatId": "e0d16f2c-c175-4c6a-8d80-f841a8242c55",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides present Pegzilarginase's efficacy in reducing arginine levels and improving mobility.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 5,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f",
      "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.",
      "position": 1,
      "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}